{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,12,14]],"date-time":"2025-12-14T12:05:23Z","timestamp":1765713923090},"reference-count":8,"publisher":"Elsevier BV","issue":"6","license":[{"start":{"date-parts":[[2019,11,1]],"date-time":"2019-11-01T00:00:00Z","timestamp":1572566400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":["clinicalkey.es","elsevier.es","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Reumatolog\u00eda Cl\u00ednica"],"published-print":{"date-parts":[[2019,11]]},"DOI":"10.1016\/j.reuma.2017.11.013","type":"journal-article","created":{"date-parts":[[2018,2,16]],"date-time":"2018-02-16T00:59:38Z","timestamp":1518742778000},"page":"360-362","update-policy":"http:\/\/dx.doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":3,"title":["Relaci\u00f3n de calprotectina fecal y anti saccharomyces antisacaromices con otros marcadores de actividad en pacientes con espondiloartritis"],"prefix":"10.1016","volume":"15","author":[{"given":"Mar\u00eda Jos\u00e9","family":"Moreno Mart\u00ednez","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Manuel Jos\u00e9","family":"Moreno Ramos","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Luis Francisco","family":"Linares Ferrando","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.reuma.2017.11.013_bib0045","doi-asserted-by":"crossref","first-page":"R261","DOI":"10.1186\/ar4106","article-title":"Marker of intestinal inflammation in patients with ankylosing spondylitis: A pilot study","volume":"14","author":"Matzkies","year":"2012","journal-title":"Arthritis Res Ther."},{"key":"10.1016\/j.reuma.2017.11.013_bib0050","doi-asserted-by":"crossref","first-page":"1746","DOI":"10.1136\/annrheumdis-2014-205506","article-title":"Calprotectin serum level is an independent marker for radiographic spinal progression in axial spondyloarthritis","volume":"73","author":"Turina","year":"2014","journal-title":"Ann Rheum Dis."},{"key":"10.1016\/j.reuma.2017.11.013_bib0055","doi-asserted-by":"crossref","first-page":"413","DOI":"10.1186\/s13075-014-0413-4","article-title":"Calprotectin (S100A8\/9) as serum biomarker for clinical response in proof-of-concept trials in axial and peripheral spondyloarthritis","volume":"16","author":"Turina","year":"2014","journal-title":"Arthritis Res Ther."},{"key":"10.1016\/j.reuma.2017.11.013_bib0060","first-page":"1569","article-title":"Role of fecal calprotectin in gastrointestinal disorders","volume":"17","author":"Montalto","year":"2013","journal-title":"Eur Rev Med Pharmacol Sci."},{"key":"10.1016\/j.reuma.2017.11.013_bib0065","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1007\/s40291-013-0016-9","article-title":"Calprotectin in rheumatoid arthritis: Association with disease activity in a cross-sectional and a longitudinal cohort","volume":"17","author":"Garcia-Arias","year":"2013","journal-title":"Mol Diagn Ther."},{"key":"10.1016\/j.reuma.2017.11.013_bib0070","first-page":"2089","article-title":"S100 proteins calprotectin and S100A12 are related to radiographic changes rather than disease activity in psoriatic arthritis with low disease activity","volume":"34","author":"Madiand","year":"2007","journal-title":"J Rheumatol."},{"key":"10.1016\/j.reuma.2017.11.013_bib0075","doi-asserted-by":"crossref","first-page":"644","DOI":"10.1038\/ajh.2012.12","article-title":"Effect of 1-year anti-TNF-\u03b1 therapy on aortic stiffness, carotid atherosclerosis, and calprotectin in inflammatory arthropathies: A controlled study","volume":"25","author":"Angel","year":"2012","journal-title":"Am J Hypertens."},{"key":"10.1016\/j.reuma.2017.11.013_bib0080","doi-asserted-by":"crossref","first-page":"28","DOI":"10.3109\/00365521.2015.1066421","article-title":"Effect of oral diclofenac intake on faecal calprotectin","volume":"51","author":"Rendek","year":"2016","journal-title":"Scand J Gastroenterol."}],"container-title":["Reumatolog\u00eda Cl\u00ednica"],"original-title":[],"language":"es","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1699258X17303017?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1699258X17303017?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2019,11,19]],"date-time":"2019-11-19T12:22:14Z","timestamp":1574166134000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1699258X17303017"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,11]]},"references-count":8,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2019,11]]}},"alternative-id":["S1699258X17303017"],"URL":"https:\/\/doi.org\/10.1016\/j.reuma.2017.11.013","relation":{},"ISSN":["1699-258X"],"issn-type":[{"value":"1699-258X","type":"print"}],"subject":[],"published":{"date-parts":[[2019,11]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Relaci\u00f3n de calprotectina fecal y anti saccharomyces antisacaromices con otros marcadores de actividad en pacientes con espondiloartritis","name":"articletitle","label":"Article Title"},{"value":"Reumatolog\u00eda Cl\u00ednica","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.reuma.2017.11.013","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"simple-article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2017 Elsevier Espa\u00f1a, S.L.U. and Sociedad Espa\u00f1ola de Reumatolog\u00eda y Colegio Mexicano de Reumatolog\u00eda. All rights reserved.","name":"copyright","label":"Copyright"}]}}